Title: Reporting Entity
Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance and 45 CFR Part 75 Appendix E, hospital cost principles, wherein certain types of expenditures are not allowable or are limited as reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the consolidated financial statements.
De Minimis Rate Used: N
Rate Explanation: Geisinger has not elected to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance.
Geisinger includes all federal expenditures in its consolidated schedule of expenditures of federal awards (the Schedule) administered by all entities included in its consolidated financial statements. Specifically, the Schedule includes expenditures of the following entities: Geisinger Health Foundation (identification number 23-1995911); Geisinger Clinic (identification number 23-6291113); Geisinger Medical Center (identification number 24-0795959); Geisinger Wyoming Valley Medical Center (identification number 23-1996150); Geisinger Community Health Services (identification number 23-2967235); Geisinger-Bloomsburg Hospital (identification number 23-2193572); Geisinger-Lewistown Hospital (identification number 23-1352187); Geisinger-Community Medical Center (identification number 24-0862246); Geisinger Health Plan (identification number 23-2311553); Geisinger Jersey Shore Hospital (identification number 24-0792115); Geisinger Commonwealth School of Medicine (identification number 26-0812968); and Geisinger HM Joint Venture, LLC (identification number 83-1871064).
Title: Basis of Preparation
Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance and 45 CFR Part 75 Appendix E, hospital cost principles, wherein certain types of expenditures are not allowable or are limited as reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the consolidated financial statements.
De Minimis Rate Used: N
Rate Explanation: Geisinger has not elected to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance.
The accompanying Schedule includes all the federal award programs activity of Geisinger under programs of the federal government for the year ended December 31, 2023. The information in this Schedule is presented in accordance with the requirements of the Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). The Schedule presents only a selected portion of the operations of Geisinger, and it is not intended to and does not present the consolidated financial position, results of operations, or cash flows of Geisinger.
Title: Summary of Significant Accounting Policies
Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance and 45 CFR Part 75 Appendix E, hospital cost principles, wherein certain types of expenditures are not allowable or are limited as reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the consolidated financial statements.
De Minimis Rate Used: N
Rate Explanation: Geisinger has not elected to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance.
Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance and 45 CFR Part 75 Appendix E, hospital cost principles, wherein certain types of expenditures are not allowable or are limited as reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the consolidated financial statements.
Title: Indirect Cost
Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance and 45 CFR Part 75 Appendix E, hospital cost principles, wherein certain types of expenditures are not allowable or are limited as reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the consolidated financial statements.
De Minimis Rate Used: N
Rate Explanation: Geisinger has not elected to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance.
Geisinger has not elected to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance.
Title: Provider Relief Fund
Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance and 45 CFR Part 75 Appendix E, hospital cost principles, wherein certain types of expenditures are not allowable or are limited as reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the consolidated financial statements.
De Minimis Rate Used: N
Rate Explanation: Geisinger has not elected to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance.
The Provider Relief Fund expenditures reported on the Schedule include the payments received from January 1, 2022 – December 31, 2022 for a period of availability expenses and/or loss revenues from January 1, 2020 through December 31, 2023 totaling $11,632,955 and include the following providers and amounts reported for period 5 in the PRF Reporting Portal. See the Notes to the SEFA for chart/table.
Geisinger Medical Center, Tax ID 24-0795959, Period 5 Expenditures of $4,073,899
Geisinger Wyoming Valley Medical Center, Tax ID 23-1996150, Period 5 Expenditures of $7,520,136
Geisinger-HM Joint Venture, LLC, Tax ID 83-1871064, Period 5 Expenditures of 38,920
Total Period 5 Expenditures of $ 11,632,955
Title: Federal Direct Loan Program
Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance and 45 CFR Part 75 Appendix E, hospital cost principles, wherein certain types of expenditures are not allowable or are limited as reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the consolidated financial statements.
De Minimis Rate Used: N
Rate Explanation: Geisinger has not elected to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance.
For the Federal Direct Student Loan Program, Geisinger is only responsible for the performance of certain administrative duties; therefore, the associated net assets and transactions are not included in Geisinger’s
consolidated financial statements and it is not practicable to determine the balances of loans outstanding to students of Geisinger under this program at December 31, 2023. The Schedule includes the amounts loaned to students during the year ended December 31, 2023.
Title: Program Expenditures Incurred in Prior Years
Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance and 45 CFR Part 75 Appendix E, hospital cost principles, wherein certain types of expenditures are not allowable or are limited as reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the consolidated financial statements.
De Minimis Rate Used: N
Rate Explanation: Geisinger has not elected to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance.
During the year ended December 31, 2023, the Pennsylvania Emergency Management Agency subawarded to Geisinger federal funding obligated in 2023 by the U.S. Department of Homeland Security through the Federal Emergency Management Agency totaling $56,982,143 for various project expenditures that were incurred in prior years.